CIK 0001321834
- Non-accelerated filer
- Smaller reporting company
Q/C TECHNOLOGIES, INC.
Sign in to watch- Ticker
- QCLS
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 856-848-8698
- Business address
- 1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
- Former names
- Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13D Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13D Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
Page 1 of 3 · 55 filings